The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment

@article{SachsEricsson2015TheND,
  title={The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment},
  author={Natalie J Sachs-Ericsson and Dan G. Iii Blazer},
  journal={Aging \& Mental Health},
  year={2015},
  volume={19},
  pages={12 - 2}
}
The Diagnostic Statistical Manual-5 (DSM-5) has included a category named the neurocognitive disorder which was formally known in DSM-IV as ‘dementia, delirium, amnestic, and other cognitive disorders’. The DSM-5 distinguishes between ‘mild’ and ‘major’ neurocognitive disorders. Major neurocognitive disorder replaces the DSM-IV's term ‘dementia or other debilitating conditions’. A pivotal addition is ‘mild neurocognitive disorder (mNCD)’ defined by a noticeable decrement in cognitive… 
Mild Neurocognitive Disorder: An Old Wine in a New Bottle
TLDR
While the category “mild NCD” may improve reliability of diagnoses, it has yet to withstand scientific scrutiny to be considered a valid construct.
Prevalence Rates of Dementia and Mild Cognitive Impairment Are Affected by the Diagnostic Parameter Changes for Neurocognitive Disorders in the DSM-5 in a Korean Population
TLDR
Diagnostic discrepancies between major/mild NCDs and dementia/MCI might depend on the operationalization of neuropsychological performance criteria.
Prevalence of DSM-5 Mild Neurocognitive Disorder in Dementia-Free Older Adults: Results of the Population-Based LIFE-Adult-Study.
TLDR
By considering all six predefined neurocognitive domains, a substantial proportion of dementia-free older adults having miNCD is observed, and Provision of information on the underlying etiology/ies may be of prime importance in future studies aiming at evaluating the clinical relevance of the mi NCD syndrome.
Mild cognitive impairment definitions: more evolution than revolution.
TLDR
Whether new MCI criteria proposed include the recent construct of mild neurocognitive disorder in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders provide clearer conceptualization of MCI is discussed to highlight implications for research.
Neuropsychiatric Symptoms of Major or Mild Neurocognitive Disorders
TLDR
This chapter will provide a concise overview of non-cognitive symptoms of NCDs including the nature, prevalence, assessment, and management of these behaviors.
Neuropsychiatric Symptoms in Mild Cognitive Impairment
TLDR
Recognition of NPS as early manifestations of neurocognitive disorders will become increasingly important as the authors move towards preventative strategies and disease-modifying treatments that may be most effective when deployed in the earliest stages of disease.
Operationalizing the Diagnostic Criteria for Mild Cognitive Impairment: The Salience of Objective Measures in Predicting Incident Dementia.
  • H. Brodaty, L. Aerts, +8 authors P. Sachdev
  • Psychology, Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2017
TLDR
Not MCI, but objective cognitive impairment alone, is the best predictor for progression to dementia in a community sample, Nevertheless, clinical assessment procedures need to be refined to improve the identification of pre-dementia individuals.
Problems in Classifying Mild Cognitive Impairment (MCI): One or Multiple Syndromes?
TLDR
The present work will contemplate the most relevant attempts to clarify the issue of MCI categorization and classification, combining the own data with that from recent studies which suggest the role of relevant psychosocial factors in MCI.
Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition.
  • J. Cummings, Luiz Cortez Pinto, +16 authors M. Sano
  • Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2020
TLDR
Criteria were revised to apply to psychosis occurring with all major and mild neurocognitive disorders to advance many types of research including development of much needed pharmacologic and nonpharmacologic interventions for psychosis in patients with neuroc cognitive disorders.
Early diagnosis of mild cognitive impairment and mild dementia through basic and instrumental activities of daily living: Development of a new evaluation tool
TLDR
This evaluation of b- and i-ADL can contribute to the diagnostic differentiation between cognitively healthy ageing and neurocognitive disorders in older age by using an ICF-based terminology and scoring system.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 151 REFERENCES
Mild cognitive impairment: a subset of minor neurocognitive disorder?
  • Y. Geda, Z. Nedelska
  • Psychology, Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2012
TLDR
The six papers published in this edition of the journal pertain to mild cognitive impairment, which is envisaged to become a subset of minor neurocognitive disorders, and all the studies addressed the symptomatic phase of AD.
Classification of neurocognitive disorders in DSM-5: a work in progress.
  • M. Ganguli, D. Blacker, +5 authors P. Sachdev
  • Psychology, Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2011
T Neurocognitive Disorders (NCDs) Work Group of the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Task Force began work in April 2008 on their
Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.
The aim of the study is to evaluate whether depression or apathy in patients with amnestic-mild cognitive impairment (MCI) increases the risk of progressing to Alzheimer's disease (AD). We
Neuropsychiatric Manifestations in Mild Cognitive Impairment: A Systematic Review of the Literature
TLDR
The behavioral changes observed in MCI are similar to those of AD and may help identify the subgroup of MCI patients with prodromal AD, and large prospective longitudinal studies would greatly contribute to the understanding of the epidemiology, diagnostic and prognostic value of the neuropsychiatric features inMCI.
Current concepts in mild cognitive impairment.
TLDR
A group of experts on aging and MCI from around the world in the fields of neurology, psychiatry, geriatrics, neuropsychology, neuroimaging, neuropathology, clinical trials, and ethics was convened to summarize the current state of the field of MCI.
Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease
TLDR
For MCI as a prodromal syndrome of AD, clinical trials with disease modifying drugs that target underlying pathological mechanisms such as amyloid-beta accumulation and neurofibrillary tangle formation may help develop effective treatment options in the future.
Predictors of progression from mild cognitive impairment to Alzheimer disease
TLDR
The predictive validity of mild cognitive impairment (MCI) for identifying future Alzheimer disease (AD) cases is improved in the presence of anxiety symptoms, which might be related to the neuropathologic mechanism.
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
TLDR
These are the first population-based estimates for neuropsychiatric symptoms in MCI, indicating a high prevalence associated with this condition as well.
Late-life depression, mild cognitive impairment, and dementia: possible continuum?
  • F. Panza, V. Frisardi, +9 authors V. Solfrizzi
  • Psychology, Medicine
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
  • 2010
Clinical and epidemiologic research has focused on the identification of risk factors that may be modified in predementia syndromes, at a preclinical and early clinical stage of dementing disorders,
Mild cognitive impairment as a clinical entity and treatment target.
TLDR
This work concludes that a diagnostic approach combining a careful, structured interview and the appropriate neuropsychological tests can discriminate those individuals with MCI likely to experience cognitive deterioration from those with a benign prognosis.
...
1
2
3
4
5
...